Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iptakalim, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (KATP) opener, as well as an α4β2-containing nicotinic acetylcholine receptor (nAChR) antagonist. Iptakalim is also a K(ir) 6.1/SUR2B activator that can attenuate hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 48.00 | |
10 mg | In stock | $ 74.00 | |
25 mg | In stock | $ 148.00 | |
50 mg | In stock | $ 241.00 | |
100 mg | In stock | $ 363.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 59.00 |
Description | Iptakalim, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (KATP) opener, as well as an α4β2-containing nicotinic acetylcholine receptor (nAChR) antagonist. Iptakalim is also a K(ir) 6.1/SUR2B activator that can attenuate hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection. |
Molecular Weight | 179.731 |
Formula | C9H22ClN |
CAS No. | 642407-63-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/ml (333.83 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iptakalim Hydrochloride 642407-63-4 Membrane transporter/Ion channel Neuroscience Potassium Channel AChR inhibit potassium Inhibitor Nicotinic acetylcholine receptors KATP PASMC Iptakalim channel eNOS KcsA Akt nAChR inhibitor